United States Biotechnology & Medical Research

Tharimmune Inc (THAR)

Track

Tharimmune Inc experienced eight recent sell transactions totaling approximately $343,882. All these disposals were executed by Gary S. Stetz during late May 2026. These divestments follow previous buying activity observed throughout 2025. The stock currently trades near the lower end of its fifty-two-week range following the company's most recent December results.
Ticker: THAR Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tharimmune Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 26 May 2026
Value US$883,175.62 | Price 497.90 | Shares 99,065 (+43.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-27 2026-05-26 S Sale
Stetz Gary S.
Non-Executive Director
99,065 +43.4%
497.90
US$883,176 		99,065 +43.4% 497.90 US$883,176
2026-05-27 2026-05-22 S Sale
Stetz Gary S.
Non-Executive Director
43,469 +34.0%
342.35
US$3,441,441 		43,469 +34.0% 342.35 US$3,441,441
2026-05-27 2026-05-22 S Sale
Stetz Gary S.
Non-Executive Director
99,394 -40.2%
450.00
US$2,336,138 		99,394 -40.2% 450.00 US$2,336,138
2026-05-27 2026-05-22 S Sale
Stetz Gary S.
Non-Executive Director
15,000 -8.1%
3.41
US$51,150 		15,000 -8.1% 3.41 US$51,150
2026-05-27 2026-05-22 S Sale
Stetz Gary S.
Non-Executive Director
15,000 -7.5%
3.41
US$51,150 		15,000 -7.5% 3.41 US$51,150
2026-05-27 2026-05-22 S Sale
Stetz Gary S.
Non-Executive Director
15,000 -7.0%
3.40
US$51,000 		15,000 -7.0% 3.40 US$51,000
2026-05-27 2026-05-22 S Sale
Stetz Gary S.
Non-Executive Director
10,000 -4.5%
3.45
US$34,500 		10,000 -4.5% 3.45 US$34,500
2026-05-27 2026-05-22 S Sale
Stetz Gary S.
Non-Executive Director
10,000 -4.3%
3.45
US$34,500 		10,000 -4.3% 3.45 US$34,500
2025-06-23 2025-06-20 B Purchase
3.3
Gravitas Capital LP

Executive Chairman

Executive Director Large shareholder
337,838 +85.6%
1.48
US$500,000 		337,838 +85.6% 1.48 US$500,000
2025-06-23 2025-06-20 B Purchase
3.7
Parikh Sanam
Non-Executive Director
1,000 +129.9%
1.45
US$1,450 		1,000 +129.9% 1.45 US$1,450
2025-06-23 2025-06-20 B Purchase
4.0
Appajosyula Sireesh

Chief Executive Officer

Executive Director
690 +1.1%
1.42
US$980 		690 +1.1% 1.42 US$980
2025-06-23 2025-06-20 B Purchase
4.0
Appajosyula Sireesh

Chief Executive Officer

Executive Director
60,806 +1803.3%
1.48
US$89,993 		60,806 +1803.3% 1.48 US$89,993
2025-05-16 2025-05-15 B Purchase
3.7
Parikh Sanam
Non-Executive Director
770 +inf%
1.30
US$1,001 		770 +inf% 1.30 US$1,001
2024-12-20 2024-12-19 B Purchase
2.1
MILBY RANDY

CEO

Executive Director
4,600 +35.6%
2.12
US$9,752 		4,600 +35.6% 2.12 US$9,752
2024-11-13 2024-11-13 B Purchase
4.0
Appajosyula Sireesh

Chief Operating Officer

Executive Director
5,000 +86.8%
2.02
US$10,096 		5,000 +86.8% 2.02 US$10,096
2024-10-10 2024-10-08 B Purchase
2.1
MILBY RANDY

CEO

Executive Director
354 +2.8%
2.10
US$743 		354 +2.8% 2.10 US$743
2024-10-10 2024-10-08 B Purchase
2.1
MILBY RANDY

CEO

Executive Director
646 +5.4%
2.09
US$1,350 		646 +5.4% 2.09 US$1,350
2024-10-10 2024-10-08 B Purchase
2.1
MILBY RANDY

CEO

Executive Director
1,500 +14.4%
2.09
US$3,128 		1,500 +14.4% 2.09 US$3,128
2024-10-08 2024-10-08 B Purchase
4.0
Appajosyula Sireesh

Chief Operating Officer

Executive Director
5,000 +44.0%
1.93
US$9,650 		5,000 +44.0% 1.93 US$9,650
2023-12-18 2023-12-15 B Purchase
2.1
MILBY RANDY

CEO

Executive Director
29,000 +22.7%
0.50
US$14,587 		29,000 +22.7% 0.50 US$14,587
2023-12-04 2023-11-30 B Purchase
2.1
MILBY RANDY

CEO

Executive Director
10,000 +8.5%
1.00
US$10,000 		10,000 +8.5% 1.00 US$10,000
2022-06-21 2022-06-17 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director Large shareholder
500 +0.0%
0.78
US$390 		500 +0.0% 0.78 US$390
2022-06-07 2022-06-06 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
500 +0.0%
0.70
US$350 		500 +0.0% 0.70 US$350
2022-06-07 2022-06-06 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
66 +0.0%
0.67
US$44 		66 +0.0% 0.67 US$44
2022-06-07 2022-06-06 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
100 +0.0%
0.67
US$67 		100 +0.0% 0.67 US$67
2022-06-07 2022-06-06 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
100 +0.0%
0.67
US$67 		100 +0.0% 0.67 US$67
2022-06-07 2022-06-06 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
234 +0.0%
0.68
US$160 		234 +0.0% 0.68 US$160
2022-06-02 2022-06-01 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
1
0.94
US$1 		1 0.94 US$1
2022-05-25 2022-05-25 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
800 +0.0%
0.79
US$632 		800 +0.0% 0.79 US$632
2022-05-25 2022-05-25 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
200 +0.0%
0.77
US$154 		200 +0.0% 0.77 US$154
2022-05-23 2022-05-20 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
500 +0.0%
0.95
US$473 		500 +0.0% 0.95 US$473
2022-05-23 2022-05-20 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
500 +0.0%
0.89
US$445 		500 +0.0% 0.89 US$445
2022-05-19 2022-05-19 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
500 +0.0%
0.90
US$450 		500 +0.0% 0.90 US$450
2022-05-19 2022-05-19 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
500 +0.0%
0.92
US$458 		500 +0.0% 0.92 US$458
2022-01-18 2022-01-14 B Purchase
Mazur Leonard L
Non-Executive Director
25,000 +25.3%
4.00
US$100,000 		25,000 +25.3% 4.00 US$100,000
Explore more

More insider trading research around Tharimmune Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America